Clinical Gut Health Intelligence
Providing the latest research on the original De Simone Formulation (CDS22) and high-potency microbiome support in the UK. All content is clinically reviewed to ensure accuracy for patients and healthcare professionals.
The UK’s Specialist Hub for Probiotic Evidence & Gut Health Research
Welcome to the Probiotics UK & Gut Health Knowledge Hub, the central resource for evidence-based research on the original De Simone Formulation (CDS22). This hub provides UK readers, patients, and healthcare professionals with clinical guides, high-potency strain comparisons, and the latest gastroenterology updates dispatched from our Lancashire facility.
Every article published here is curated to support the NHS IBD care pathways and private clinical protocols. We focus exclusively on the Original 8-Strain De Simone Formulation (CDS22), ensuring our readers have access to the exact science backed by over 200 peer-reviewed studies. From our cold-chain facility in Chorley, we monitor the latest developments in gut health to keep the UK medical community informed.
CDS22-formula and Optibac Every Day are two popular probiotics in the UK, but they differ in strength, strains and clinical heritage. This neutral, evidence-based comparison explains how Optibac’s 5B CFU daily capsule compares with the much higher-strength 112B CFU De Simone Formulation. Helpful for UK readers researching everyday probiotics versus specialist formulations. Not medical advice.
Read more
A UK-focused, evidence-based comparison of probiotics for ulcerative colitis, IBS and pouchitis, including guideline positions and clinical trial summaries.
Read more